100 Participants Needed

Conversational Data Collection for Chronic Pain

(CADS Trial)

SC
MR
Overseen ByMark Ruchman, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: AugMend Health Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if digital tools can effectively collect health information about chronic pain through conversation-like interactions. Participants will use these tools, including the Digital Biopsychosocial Conversational Data Collection Software, to share details about their pain experiences, emotional well-being, and social factors. The main goal is to assess whether these tools are easy and practical for patients to use in real-world settings. Ideal participants are those who have experienced chronic pain for at least three months and can interact with digital platforms in English. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance chronic pain management for many.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on using digital tools to collect information about your chronic pain, so it's unlikely that you would need to change your medication routine.

What prior data suggests that these digital conversational tools are safe for collecting health information from patients with chronic pain?

A previous study found that patients with chronic pain responded well to using digital tools for health information collection. Research shows these tools are generally safe, as they are software-based and involve minimal risk. Unlike medications or medical devices, this software interacts with users like a conversation with a healthcare provider.

Initial findings suggest that patients have had positive experiences using these digital tools for managing chronic pain. Reports indicate that these tools are easy to use and have no known negative effects. Since this is software and not a medication, the focus is on ease and practicality for patients rather than side effects.

Overall, evidence shows the digital software is safe, user-friendly, and can be a helpful addition to managing chronic pain.12345

Why are researchers excited about this trial?

Researchers are excited about the trial for the digital biopsychosocial conversational data collection software because it offers a fresh approach to understanding and managing chronic pain. Unlike traditional methods, which often rely on standard questionnaires and interviews, this digital tool allows for a more dynamic and comprehensive collection of data about patients' pain experiences, emotional well-being, and social circumstances. The software's interactive nature not only aims to improve the accuracy and depth of information gathered but also enhances patient engagement by making the process more intuitive and user-friendly. By evaluating its acceptability, feasibility, and usability, researchers hope to find out if this digital approach could lead to better insights and potentially more personalized pain management strategies.

What evidence suggests that this trial's digital data collection methods could be effective for chronic pain?

Research has shown that digital health tools, like chat software, can help manage chronic pain by gathering important health information. In this trial, participants in one arm will use the Digital Biopsychosocial Conversational Data Collection Software. This software is designed to mimic conversations with healthcare providers, making data collection more natural and engaging. One study found that these tools effectively collect data on physical symptoms, emotions, and social interactions, which are key to understanding chronic pain. Patients have reported that these digital tools are easy to use and helpful in providing a complete picture of their health. Meanwhile, participants in the control arm will use the Standard Digital Questionnaire Data Collection method. Overall, evidence suggests these digital tools offer a practical way to gather detailed health information from people with chronic pain.12567

Who Is on the Research Team?

AT

Alexandra Therond, MA

Principal Investigator

AugMend Health

MR

Mark Ruchman, MD

Principal Investigator

AugMend Health

Are You a Good Fit for This Trial?

This study is for adults over 18 with chronic pain lasting more than 3 months, who can read English and give informed consent. Participants should be able to complete tasks at home or travel to the MIT.nano Immersion Lab if needed, have access to technology for home participation, and be cognitively capable of interacting with digital tools.

Inclusion Criteria

I am 18 years old or older.
I have been experiencing pain for 3 months or more.
I can read and understand English.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Data Collection

Participants interact with digital software to provide biopsychosocial information about their chronic pain condition.

1-2 weeks
Home-based or MIT.nano Immersion Lab sessions

Follow-up

Participants are monitored for usability, feasibility, and acceptability of the digital tools.

1-2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Digital Biopsychosocial Conversational Data Collection Software
  • Standard Digital Questionnaire Data Collection

Trial Overview

The trial is testing conversational software that collects health information from patients by simulating a natural conversation. It aims to see how well these tools gather comprehensive biopsychosocial data in those experiencing chronic pain.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Experimental Digital Biopsychosocial Data Collection SoftwareExperimental Treatment1 Intervention
Group II: Control Standard Data Collection MethodActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

AugMend Health Inc.

Lead Sponsor

Citations

Evaluating the Acceptability, Feasibility and Usability of ...

This research study is being conducted to evaluate digital software tools that collect health information through conversations.

Effectiveness of Digital Health Interventions (DHI) in Chronic ...

The following study identifies and assesses DHIs' efficacy in specific chronic pain conditions and then extrapolates improved outcomes and ...

Conversational Data Collection for Chronic Pain (CADS Trial)

The study will test how acceptable, feasible, and usable these conversational software programs are for patients with chronic pain.

Implementation outcomes of a biopsychosocial model pain...

A prospective interventional study was conducted to evaluate the efficacy and implementation outcomes of the biopsychosocial model (BPS)-based CPM protocol ...

Patients' Experiences of Digital Health Interventions for the ...

Research regarding the effectiveness of digital health interventions (DHIs) for people living with chronic pain is widely documented, ...

Conversational Agents to Support Pain Management

This scoping review aims to comprehensively evaluate the applications and effectiveness of conversational agents in supporting pain management in adults.

Professional-Facing Digital Health Technology for the Care ...

This scoping review aims to identify the available professional-facing DHTs for chronic pain management.